Skip to content

CRH CRH Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

Arthur J. Gallagher logo
Arthur J. GallagherAJG
$11M
Arthur J. Gallagher logo
Arthur J. GallagherAJG
$1.17B-92.9%
Arthur J. Gallagher logo
Arthur J. GallagherAJG
$8.48B-61.9%
EFC
Ellington Financial Inc.EFC
$368M-6.5%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$2.29B-7.6%
NYM
NYMTNYMT

Other financials

Income statement

See full
Revenue$7.4B+9.1%
Gross profit$2.0B+11.3%
Operating income-$38.0M-311%
Net income-$176.0M-87.2%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$3.2B-3.3%
Total debt$18.1B+13.1%
Total equity$23.1B+9.2%
Total assets$58.2B+12.0%

Cash flow

See full
Operating cash flow-$616.0M+6.5%
CapEx$601.0M-6.8%
Free cash flow-$1.2B+6.7%

Valuation

See full
Market cap$74.33B+18.0%
Enterprise value$89.15B+17.9%
P/E20.3×+1.0×
P/S+0.2×

Profitability

See full
Gross margin36.1%+0.5pp
Operating margin14.1%+0.4pp
Net margin9.6%+0.5pp

Returns & leverage

See full
Return on equity16.6%+0.7pp
Debt / equity0.8×0.0×
Current ratio1.6×0.0×

Where this comes from

Reported directly by CRH in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: CRH’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRH's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CRH's cash and cash equivalents, end of period?
CRH (CRH) reported cash and cash equivalents, end of period of $3.33B in Q1 2026.
How has CRH's cash and cash equivalents, end of period changed year-over-year?
CRH's cash and cash equivalents, end of period decreased by 0.6% year-over-year, from $3.35B to $3.33B.
What is the long-term trend for CRH's cash and cash equivalents, end of period?
Over 3 years (2022 to 2025), CRH's cash and cash equivalents, end of period has grown at a -11.3% compound annual growth rate (CAGR), from $5.94B to $4.15B.